Cargando…
Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597891/ https://www.ncbi.nlm.nih.gov/pubmed/34841682 http://dx.doi.org/10.1002/ctm2.598 |
| _version_ | 1784600694239526912 |
|---|---|
| author | Long, Junyu Yang, Xu Bian, Jin Wang, Dongxu Wang, Anqiang Lin, Yu Zheng, Mingjun Zhang, Haohai Sang, Xinting Zhao, Haitao |
| author_facet | Long, Junyu Yang, Xu Bian, Jin Wang, Dongxu Wang, Anqiang Lin, Yu Zheng, Mingjun Zhang, Haohai Sang, Xinting Zhao, Haitao |
| author_sort | Long, Junyu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8597891 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85978912021-12-06 Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy Long, Junyu Yang, Xu Bian, Jin Wang, Dongxu Wang, Anqiang Lin, Yu Zheng, Mingjun Zhang, Haohai Sang, Xinting Zhao, Haitao Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-11-17 /pmc/articles/PMC8597891/ /pubmed/34841682 http://dx.doi.org/10.1002/ctm2.598 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Long, Junyu Yang, Xu Bian, Jin Wang, Dongxu Wang, Anqiang Lin, Yu Zheng, Mingjun Zhang, Haohai Sang, Xinting Zhao, Haitao Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_full | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_fullStr | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_full_unstemmed | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_short | Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy |
| title_sort | identification of tmb, cd8 t‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐pd‐1/pd‐l1 therapy |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597891/ https://www.ncbi.nlm.nih.gov/pubmed/34841682 http://dx.doi.org/10.1002/ctm2.598 |
| work_keys_str_mv | AT longjunyu identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT yangxu identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT bianjin identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT wangdongxu identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT wanganqiang identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT linyu identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT zhengmingjun identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT zhanghaohai identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT sangxinting identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy AT zhaohaitao identificationoftmbcd8tcellabundanceandhomologousrepairpathwaymutationfrequencyaspredictorsofthebenefittoxicityratioofantipd1pdl1therapy |